Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VRDN

Viridian Therapeutics Inc

May 29 • 04:00PM ET

17.62

+0.17 0.97 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR RYTM BMRN KRYS NUVL VKTX AXSM MDGL INCY NBIX

| Held by: XBI VTI IWM VXF IWO SCHA VTWO DFAS DFMC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.76	Insider Own	7.18%	Shs Outstand	110.43M	Perf Week	-0.40%
Market Cap	1.95B	Forward P/E	-	EPS next Y	-2.42	Insider Trans	17.38%	Shs Float	102.50M	Perf Month	32.48%
Enterprise Value	1.37B	PEG	-	EPS next Q	-1.03	Inst Own	101.07%	Short Float	13.92%	Perf Quarter	-40.03%
Income	-342.21M	P/S	27.44	EPS this Y	-13.60%	Inst Trans	9.43%	Short Ratio	5.08	Perf Half Y	-43.90%
Sales	70.92M	P/B	3.58	EPS next Y	35.80%	ROA	-47.20%	Short Interest	14.27M	Perf YTD	-43.38%
Book/sh	4.92	P/C	2.55	EPS next 5Y	61.40%	ROE	-55.17%	52W High	34.29 -48.61%	Perf Year	26.13%
Cash/sh	6.90	P/FCF	-	EPS past 3/5Y	6.35% 36.07%	ROIC	-49.85%	52W Low	13.18 33.69%	Perf 3Y	-25.75%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	241.95% 132.18%	Gross Margin	98.50%	Volatility	4.06% 5.43%	Perf 5Y	-2.17%
Dividend TTM	-	EV/Sales	19.27	EPS Y/Y TTM	7.01%	Oper. Margin	-543.86%	ATR (14)	0.96	Perf 10Y	-87.16%
Dividend Ex-Date	-	Quick Ratio	15.15	Sales Y/Y TTM	23382.78%	Profit Margin	-482.55%	RSI (14)	54.17	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	15.15	EPS Q/Q	3.94%	SMA20	4.67%	Beta	0.89	Target Price	33.94
Payout	-	Debt/Eq	0.08	Sales Q/Q	95.83%	SMA50	0.29%	Rel Volume	0.50	Prev Close	17.45
Employees	252	LT Debt/Eq	0.08	Earnings	May 05 BMO	SMA200	-27.54%	Avg Volume	2.81M	Price	17.62
IPO	Jun 18, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.74% 290.58%	Trades		Volume	1,395,074	Change	0.97%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)